The End of Alzheimer's

The End of Alzheimer's argues that Alzheimer's disease is not a single condition with a single cause but a protective response by the brain to a range of insults, and that treating it requires identifying and correcting all of them at once. Dale Bredesen's central image is a roof with 36 holes: patching one, which is what single-target drug development has attempted for decades, leaves the roof leaking.

His framework proposes subtypes — broadly inflammatory, atrophic or trophic-deficient, and toxic — distinguished by laboratory pattern and clinical presentation. The ReCODE protocol that follows is personalised and extensive: detailed testing of inflammatory markers, insulin and glucose metabolism, homocysteine, hormones, nutrient status, infections and toxic exposures, followed by an individualised program of diet, fasting, exercise, sleep optimisation, cognitive training, stress reduction and targeted supplementation. The organising idea is that enough small corrections, applied together and early, can shift the balance back toward synaptic maintenance.

It is written for people with early cognitive symptoms, for families with a strong history of dementia, and for clinicians curious about a systems approach to neurodegeneration.

On the evidence, this needs stating precisely. Bredesen is a credentialled neuroscience researcher and the underlying rationale draws on real biology. The clinical support for ReCODE, however, consists largely of small uncontrolled case series and a small proof-of-concept study without randomisation or a control group. That design cannot separate treatment effect from expectation, natural variability or selection, and the protocol has not been evaluated in a randomised controlled trial. It is not endorsed in current dementia guidelines. Separately, multidomain lifestyle interventions have shown modest cognitive benefit in at-risk older adults in controlled research, which lends general support to the direction without validating this specific program. The protocol is also demanding and expensive. Worth reading and worth discussing with a physician; not yet something the evidence allows to be described as reversal.